Strategic question
Which APAC markets, therapeutic areas and Digital Health categories should we prioritise to accelerate regional growth?
How Galen Growth helped
From market signal to decision-ready evidence
Galen Growth conducted a Digital Health readiness assessment across four APAC markets, combining disease-prevalence analysis, ecosystem benchmarking and structured venture scouting. Using HealthTech Alpha and market-specific analysis, we evaluated category maturity, investment activity, therapeutic opportunity and venture suitability against the client’s strategic objectives.
Outcomes
Identified cardio, oncology and diabetes as the most relevant priorities and clarified which markets and categories offered the strongest fit for the client’s regional strategy.
Decision enabled: Enabled regional leadership to focus investment, partnership scouting and innovation resources on the most defensible APAC opportunities.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Sourcing OMICS Ventures to Shape Oncology and Wellness Strategy
Which OMICS-led ventures tackling oncology and wellness are mature enough to partner with an enterprise insurer?
Sourcing HealthTech Ventures to Power Non-Fluid Underwriting
Which ventures across digital biomarkers, DTx, genomics and teleconsultation are mature enough to enable non-fluid underwriting?
Pressure-Testing a Digital Health Partnership Before Commitment
How does our preferred venture partner compare against credible alternatives in the same market and therapeutic focus?